Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 5
Submit an article Journal homepage
175
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Leflunomide: long-term clinical experience and new uses

J Peter KaltwasserAbteilung Rheumatologie Medizinische Klinik III, Zentrum der Inneren Medizin, J. W. Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt am MainGermany Tel: +49 69 63017301; Fax: +49 69 63015929;E-mail: [email protected]
&
Frank BehrensAbteilung Rheumatologie Medizinische Klinik III, Zentrum der Inneren Medizin, J. W. Goethe-Universität, Theodor-Stern-Kai 7, 60590 Frankfurt am MainGermany Tel: +49 69 63017301; Fax: +49 69 63015929;E-mail: [email protected]
Pages 787-801 | Published online: 10 May 2005

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Guangxin Lv & Chengyuan Ming. (2022) Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: a Meta-analysis of randomized controlled trials. Renal Failure 44:1, pages 1012-1026.
Read now

Articles from other publishers (15)

. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 498 511 .
Siddharama Pawate & Francesca Bagnato. (2015) Newer Agents in the Treatment of Multiple Sclerosis. The Neurologist 19:4, pages 104-117.
Crossref
Simon A. Broadley, Michael H. Barnett, Mike Boggild, Bruce J. Brew, Helmut Butzkueven, Robert Heard, Suzanne Hodgkinson, Allan G. Kermode, Jeannette Lechner-Scott, Richard A.L. Macdonell, Mark Marriott, Deborah F. Mason, John Parratt, Stephen W. Reddel, Cameron P. Shaw, Mark Slee, Judith Spies, Bruce V. Taylor, William M. Carroll, Trevor J. Kilpatrick, John King, Pamela A. McCombe, John D. Pollard & Ernest Willoughby. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience 21:11, pages 1847-1856.
Crossref
Yann-Erick Claessens & Luc MouthonL. Mouthon. 2013. Maladies rares en médecine d’urgence. Maladies rares en médecine d’urgence 65 87 .
Yan Sun, Xi Chen, Jiabin Zhao, Xiaoming Zou, Gang Li, Xiaolin Li, Bin Shen & Shibo Sun. (2012) Combined use of rapamycin and leflunomide in prevention of acute cardiac allografts rejection in rats. Transplant Immunology 27:1, pages 19-24.
Crossref
Steven Carsons. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome 571 578 .
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology 491 598 .
Tobias Deuse, Reinhold G. Erben, Fumiaki Ikeno, Boris Behnisch, Rainer Boeger, Andrew J. Connolly, Hermann Reichenspurner, Claudia Bergow, Marc P. Pelletier, Robert C. Robbins & Sonja Schrepfer. (2008) Introducing the first polymer-free leflunomide eluting stent. Atherosclerosis 200:1, pages 126-134.
Crossref
Joachim Peter Kaltwasser. (2007) Leflunomide in psoriatic arthritis. Autoimmunity Reviews 6:8, pages 511-514.
Crossref
Felix Braun & Matthias Behrend. 2007. 424 479 .
John M. Vierling. 2007. Liver Immunology. Liver Immunology 391 407 .
Carol A. Wallace. (2006) Current management of juvenile idiopathic arthritis. Best Practice & Research Clinical Rheumatology 20:2, pages 279-300.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2015 2024 .
K. Budde, M. Giessing, L. Liefeldt, H.-H. Neumayer & P. Glander. (2006) Moderne Immunsuppressiva nach NierentransplantationModern immunosuppression following renal transplantation. Der Urologe 45:1, pages 9-17.
Crossref
Hartmut Lins. (2005) Clinical Add-on: Multiple sclerosis – clinical picture and therapeutic strategies. Signal Transduction 5:5, pages 266-272.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.